Author
Listed:
- Shuijun Zhang
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Victor A. Kostyuchenko
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Thiam-Seng Ng
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Xin-Ni Lim
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Justin S. G. Ooi
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Sebastian Lambert
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Ter Yong Tan
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
- Douglas G. Widman
(University of North Carolina at Chapel Hill)
- Jian Shi
(Centre for BioImaging Sciences, National University of Singapore
CryoEM unit, National University of Singapore)
- Ralph S. Baric
(University of North Carolina at Chapel Hill)
- Shee-Mei Lok
(Program in Emerging Infectious Diseases, Duke–National University of Singapore Medical School
Centre for BioImaging Sciences, National University of Singapore)
Abstract
The rapid spread of Zika virus (ZIKV), which causes microcephaly and Guillain-Barré syndrome, signals an urgency to identify therapeutics. Recent efforts to rescreen dengue virus human antibodies for ZIKV cross-neutralization activity showed antibody C10 as one of the most potent. To investigate the ability of the antibody to block fusion, we determined the cryoEM structures of the C10-ZIKV complex at pH levels mimicking the extracellular (pH8.0), early (pH6.5) and late endosomal (pH5.0) environments. The 4.0 Å resolution pH8.0 complex structure shows that the antibody binds to E proteins residues at the intra-dimer interface, and the virus quaternary structure-dependent inter-dimer and inter-raft interfaces. At pH6.5, antibody C10 locks all virus surface E proteins, and at pH5.0, it locks the E protein raft structure, suggesting that it prevents the structural rearrangement of the E proteins during the fusion event—a vital step for infection. This suggests antibody C10 could be a good therapeutic candidate.
Suggested Citation
Shuijun Zhang & Victor A. Kostyuchenko & Thiam-Seng Ng & Xin-Ni Lim & Justin S. G. Ooi & Sebastian Lambert & Ter Yong Tan & Douglas G. Widman & Jian Shi & Ralph S. Baric & Shee-Mei Lok, 2016.
"Neutralization mechanism of a highly potent antibody against Zika virus,"
Nature Communications, Nature, vol. 7(1), pages 1-7, December.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13679
DOI: 10.1038/ncomms13679
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13679. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.